Survival following heart transplantation associated with several patient …News-Medical.netSurvival following heart transplantation is associated with several patient characteristics, including patient education, higher social and economic satisfactio…
|
N-acetylcysteine improves graft survival following liver transplantation
News-Medical.net “Liver transplantation is the standard treatment for end-stage liver disease,” explains lead author Dr. Francesco D’Amico from Padova University in Italy. “Antioxidants such as NAC could potentially reduce damage to deceased donor livers, improving … |
 Medical Daily |
Pretreating Liver Donors Can Boost Survivability to 93%
Medical Daily “Liver transplantation is the standard treatment for end-stage liver disease,” said lead author Dr. Francesco D’Amico from Padova University in Italy. “Antioxidants such as NAC could potentially reduce damage to deceased donor livers, improving graft … |
Antioxidant Improves Donated Liver Survival Rate to More Than 90%Science Daily (press release)Results published in the February issue of Liver Transplantation, a journal of the American Association for the Study of Liver Diseases (AASLD), suggest that …
|
Heart transplant patients are living longer, better, thanks to advancements
MiamiHerald.com That is the holy grail of transplantation and is something we have been working on for years, including myself in the research area, and we see the end of the tunnel now,” said Dr. Si Pham, chief of the Division of Heart and Lung Transplantation at the … |
The AgeLeader in heart, lung transplantationThe AgeMany innovations followed, including single-lung transplantation in 1990; double-lung transplantation in 1992; and long-term support and retrieval using then-evolving technology allowing advanced life …
Impact of acute kidney injury exposure period among liver transplantation patients7thSpace Interactive (press release)Impact of acute kidney injury exposure period among liver transplantation patients. Acute kidney injury is a common complication of li…
|
Novartis Zortress medication wins FDA nod to prevent liver transplantation …
Pharmaceutical Business Review Zortress, which is cleared for use in adults subsequent to liver transplantation, binds to mammalian target of rapamycin (mTOR) and acts with calcineurin inhibitors (CNIs) thereby, lessening the probability of CNI exposure. Novartis division head David … FDA grants fresh approval for Novartis’ ZortressPharmaTimes Novartis’ Zortress cleared by FDA for liver transplantsPMLiVE |
|
FDA approves Novartis’ Zortress to prevent organ rejection in adults after …
News-Medical.net “Novartis has been a leading innovator in the transplant field for 30 years, and this FDA approval for liver transplantation marks an important milestone for patients and their transplant physicians in the US,” said David Epstein , Division Head of … FDA Nod For Novartis Drug To Avert Organ Failure In Liver TransplantRTT News |
|
FDA Oks Novartis’s Zortress For Liver Transplantation – Quick Facts
NASDAQ According to the company, Zortress is the first mammalian target of rapamycin (mTOR) inhibitor approved for use following liver transplantation. It is also … In most EU member countries, Certican is also approved in kidney and heart transplantation … |